A US Food and Drug Administration emergency use authorization for blood plasma to treat Covid-19 is on hold, but could still be issued in the near future, Dr. H. Clifford Lane, deputy director at the National Institute of Allergy and Infectious Diseases, told The New York Times.
![](http://feeds.feedburner.com/~r/rss/cnn_topstories/~4/YkQtISRLGXE)
Source: cnn news